About Medipreço
A Brazilian healthtech dedicated to making the medication plan part of the care companies offer their teams.
Who we are
Medipreço is a Brazilian healthtech that operates the medication plan as a corporate benefit. The contracting company sets a monthly subsidy for employees to buy medication, and Medipreço delivers the platform, the network of partner pharmacies, prescription auditing, and program management.
We exist so that healthcare becomes a concrete result, not a promise: less out-of-pocket spending on medication and more treatment adherence, for companies that take the health of the people who work for them seriously.
Our history
From price comparison to a nationwide medication plan operation, Medipreço's trajectory tracks the maturation of Brazil's own corporate health benefits sector.
2019
Founded as a medication price comparison platform.
2020
Nationwide B2B operation, with delivery and payroll deduction.
2021
First investment round.
2022
Maturation and scale of the operation, with the start of work alongside health plans.
2023 to 2024
Focus on artificial intelligence and consolidation of the medication plan as a corporate benefit.
2026
ISO/IEC 27001:2022 certification and investment from BDev Ventures.
What we deliver today
Companies rely on Medipreço to set up the medication subsidy for their teams, with nationwide pharmacy coverage and delivery across Brazilian territory. Employees buy through the app, pick up at smart lockers installed at their own companies, or pay at a physical pharmacy, always with automatic prescription auditing.
For HR, this means a program configurable by company, with usage data handled in aggregated form and a support team dedicated to each account.
Board and investors
Valutia Capital and Mevo Saúde sit on the company's board, supporting governance and the growth of the operation.
In July 2026, Medipreço announced the investment from BDev Ventures, a new step in the growth of the medication plan as a corporate benefit.